OnabotulinumtoxinA Treatment for Masseter Muscle Prominence: 6-Month Safety and Efficacy Results, Including Patient-Reported Outcomes, From a Phase 3, Randomized, Placebo-Controlled, Multiregional Trial.
- DOI
- 10.1093/asj/sjaf204
- Published
- 2026 Apr 7
- Container
- Aesthetic surgery journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/asj/sjaf204,
title = {OnabotulinumtoxinA Treatment for Masseter Muscle Prominence: 6-Month Safety and Efficacy Results, Including Patient-Reported Outcomes, From a Phase 3, Randomized, Placebo-Controlled, Multiregional Trial.},
author = {Sun J and Wang L and Wu Y and Humphrey S and Chen SG and McGillivray W and Huang SH and Zhang Y and Pan G and Foley C and Lee E and Chang-Lin JE and Faletto DL and Patel V and Bowen B and Brin MF},
year = {2026},
journal = {Aesthetic surgery journal},
doi = {10.1093/asj/sjaf204},
url = {https://doi.org/10.1093/asj/sjaf204}
}RIS
TY - JOUR TI - OnabotulinumtoxinA Treatment for Masseter Muscle Prominence: 6-Month Safety and Efficacy Results, Including Patient-Reported Outcomes, From a Phase 3, Randomized, Placebo-Controlled, Multiregional Trial. AU - Sun J AU - Wang L AU - Wu Y AU - Humphrey S AU - Chen SG AU - McGillivray W AU - Huang SH AU - Zhang Y AU - Pan G AU - Foley C AU - Lee E AU - Chang-Lin JE AU - Faletto DL AU - Patel V AU - Bowen B AU - Brin MF PY - 2026 JO - Aesthetic surgery journal DO - 10.1093/asj/sjaf204 UR - https://doi.org/10.1093/asj/sjaf204 ER -
APA
J, S., L, W., Y, W., S, H., SG, C., W, M., SH, H., Y, Z., G, P., C, F., E, L., JE, C., DL, F., V, P., B, B., & MF, B. (2026). OnabotulinumtoxinA Treatment for Masseter Muscle Prominence: 6-Month Safety and Efficacy Results, Including Patient-Reported Outcomes, From a Phase 3, Randomized, Placebo-Controlled, Multiregional Trial.. Aesthetic surgery journal. https://doi.org/10.1093/asj/sjaf204
Source records
- pubmed · retrieved 2026-09-26T07:34:43.395Z
- europe-pmc · retrieved 2026-09-26T07:34:43.408Z